417 related articles for article (PubMed ID: 21952734)
1. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4).
Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I
Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657
[TBL] [Abstract][Full Text] [Related]
3. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
[TBL] [Abstract][Full Text] [Related]
4. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.
Osborne T; Roska RL; Rajski SR; Thompson PR
J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
Yang H; Ouyang Y; Ma H; Cong H; Zhuang C; Lok WT; Wang Z; Zhu X; Sun Y; Hong W; Wang H
Bioorg Med Chem Lett; 2017 Oct; 27(20):4635-4642. PubMed ID: 28927791
[TBL] [Abstract][Full Text] [Related]
6. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites.
van Haren M; van Ufford LQ; Moret EE; Martin NI
Org Biomol Chem; 2015 Jan; 13(2):549-60. PubMed ID: 25380215
[TBL] [Abstract][Full Text] [Related]
8. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.
Sack JS; Thieffine S; Bandiera T; Fasolini M; Duke GJ; Jayaraman L; Kish KF; Klei HE; Purandare AV; Rosettani P; Troiani S; Xie D; Bertrand JA
Biochem J; 2011 Jun; 436(2):331-9. PubMed ID: 21410432
[TBL] [Abstract][Full Text] [Related]
10. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
11. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases.
Dowden J; Hong W; Parry RV; Pike RA; Ward SG
Bioorg Med Chem Lett; 2010 Apr; 20(7):2103-5. PubMed ID: 20219369
[TBL] [Abstract][Full Text] [Related]
12. Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.
Hu H; Owens EA; Su H; Yan L; Levitz A; Zhao X; Henary M; Zheng YG
J Med Chem; 2015 Feb; 58(3):1228-43. PubMed ID: 25559100
[TBL] [Abstract][Full Text] [Related]
13. Förster resonance energy transfer measurements of cofactor-dependent effects on protein arginine N-methyltransferase homodimerization.
Thomas D; Lakowski TM; Pak ML; Kim JJ; Frankel A
Protein Sci; 2010 Nov; 19(11):2141-51. PubMed ID: 20812326
[TBL] [Abstract][Full Text] [Related]
14. Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.
van Haren MJ; Marechal N; Troffer-Charlier N; Cianciulli A; Sbardella G; Cavarelli J; Martin NI
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3625-3630. PubMed ID: 28330993
[TBL] [Abstract][Full Text] [Related]
15. Arginine Methylation: The Coming of Age.
Blanc RS; Richard S
Mol Cell; 2017 Jan; 65(1):8-24. PubMed ID: 28061334
[TBL] [Abstract][Full Text] [Related]
16. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
[TBL] [Abstract][Full Text] [Related]
17. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm.
Wooderchak WL; Zang T; Zhou ZS; Acuña M; Tahara SM; Hevel JM
Biochemistry; 2008 Sep; 47(36):9456-66. PubMed ID: 18700728
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
